Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2019 / Cilt: 33 - Sayı: 3

A Newborn Case Diagnosed with Thanatophoric Dysplasia Type 1

Tanatoforik Displazi Tip 1 Tanısı Konulan Bir Yenidoğan Olgusu

Pages
191–194
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thanatophoric dysplasia should be considered in the differential diagnosis of cases with skeletal dysplasia.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thanatophoric dysplasia is a lethal skeletal dysplasia manifested by short extremities which is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.
📊
Key Findings & Data:Herein, we present a case of thanatophoric dysplasia type 1 diagnosed by typical clinical and radiological findings, and FGFR3 gene analysis.
💡
Conclusion & Impact:Thanatophoric dysplasia should be considered in the differential diagnosis of cases with skeletal dysplasia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Thanatophoric dysplasia is a lethal skeletal dysplasia manifested by short extremities which is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene. Characteristically, macrocephaly, narrow thorax, flattening in the vertebrae, bowing in the femur with short and flat extremities is seen. Herein, we present a case of thanatophoric dysplasia type 1 diagnosed by typical clinical and radiological findings, and FGFR3 gene analysis. The patient born at the 34th gestational week with a 2160 g birth weight was found to have macrocephaly, marked forehead, narrow thorax, curved and short extremities on physical examination. Skeletal X-rays showed platyspondyly in the vertebral corpus, short ribs and short long tubular bones. Molecular genetic analysis revealed a heterozygous p.R248C (c.742C> T) mutation in the FGFR3 gene exon 7. Thanatophoric dysplasia should be considered in the differential diagnosis of cases with skeletal dysplasia.

Özet

Tanatoforik displazi, fibroblast büyüme faktörü reseptörü 3 (FGFR3) genindeki mutasyonun neden olduğu, kısa ekstremiteler ile kendini gösteren letal bir iskelet displazisi tablosudur. Karakteristik olarak makrosefali, dar toraks yapısı, vertebralarda düzleşme, kısa ve yassı ekstremiteler ile femurda eğrilme görülür. Burada tipik klinik ve radyolojik bulguları yanında FGFR3 gen analizi ile tanatoforik displazi tip 1 tanısı konulan bir olgu sunulmuştur. 34. gebelik haftasında 2160 g ağırlığında doğan olgunun fizik muayenesinde makrosefali, belirgin alın, dar göğüs kafesi, eğri ve kısa ekstremiteleri vardı. İskelet grafilerinde vertebra korpuslarında platispondili, kısa kostalar ve kısa uzun tübüler kemikler vardı. Moleküler genetik analizde FGFR3 geni ekzon 7’de heterozigot p.R248C (c.742C>T) mutasyonu saptandı. İskelet displazisi bulguları olan olguların ayırıcı tanısında tanatoforik displazi de düşünülmelidir. FGFR3 gen analizi yapıldıktan sonra aileye genetik danışmanlık verilmelidir.

🔖

Cite This Article

AYDIN, M., ÇETİNKAYA, P. U., HAKAN, N. (2022). A Newborn Case Diagnosed with Thanatophoric Dysplasia Type 1. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 33 - Sayı: 3, 191–194. https://ajindex.com/articles/650605

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Maroteaux P, Lamy M, Robert JM. Thanatophoric dwarfism. Presse Med 1967; 75: 2519-2524
  2. Wilcox WR, Tavormina PL, Krakow D, et al. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet 1998; 78: 274281
  3. Vogt C, Blaas HG. Thanatophoric dysplasia: Autopsy findings over a 25-year period. Pediatr Dev Pathol 2013; 16: 160-167
  4. Martínez-Frías ML, Ramos-Arroyo MA, Salvador J. Thanatophoric dysplasia: An autosomal dominant condition? Am J Med Genet 1988; 31: 815-820
  5. Baker KM, Olson DS, Harding CO, Pauli RM. Long-term survival in typical thanatophoric dysplasia type 1. Am J Med Genet 1997; 70: 427-436
  6. Tavormina PL, Shiang R, Thompson LM, et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995; 9: 321-328
  7. Rousseau F, Saugier P, Le Merrer M, et al. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat Genet 1995; 10: 11-12
  8. Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat 2012; 33: 29-41
  9. Krakow D, Alanay Y, Rimoin LP, et al. Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: A retrospective and prospective analysis. Am J Med Genet A 2008; 146A: 1917-1924
  10. Wainwright H. Thanatophoric dysplasia: A review. S Afr Med J 2016; 106: S50-53
  11. Parilla BV, Leeth EA, Kambich MP, Chilis P, MacGregor SN. Antenatal detection of skeletal dysplasias. J Ultrasound Med 2003; 22: 255-261
  12. Wong HS, Kidd A, Zuccollo J, et al. A case of thanatophoric dysplasia: The early prenatal 2D and 3D sonographic findings and molecular confirmation of diagnosis. Fetal Diagn Ther 2008; 24: 71-73
  13. Chen CP, Chern SR, Wang W, Wang TY. Secondtrimester molecular diagnosis of a heterozygous 742 --> T (R248C) mutation in the FGFR3 gene in a thanatophoric dysplasia variant following suspicious ultrasound findings. Ultrasound Obstet Gynecol 2001; 17: 272-273
  14. Xue Y, Sun A, Mekikian PB, et al. FGFR3 mutation frequency in 324 cases from the international skeletal dysplasia registry. Mol Genet Genomic Med 2014; 2: 497503
  15. Perez-Castro AV, Wilson J, Altherr MR. Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene. Genomics 1997; 41: 10-16
  16. Lievens PM, Liboi E. The thanatophoric dy